Neutralizing antibodies to HCV in prospectively followed children with perinatally acquired hepatitis C virus infection.

被引：0
|
作者：
Farci, P
Meunier, JC
Strazzera, R
Farci, S
Cao, D
Casadei, AM
Quinti, I
Vegnente, A
Coiana, A
Bukh, J
Purcell, RH
Tovo, PA
机构：
[1] Univ Cagliari, Cagliari, Italy
[2] NIH, Bethesda, MD 20892 USA
[3] Univ Roma La Sapienza, Rome, Italy
[4] Univ Naples Federico II, Naples, Italy
[5] Univ Turin, Turin, Italy
来源：
HEPATOLOGY | 2005年 / 42卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
下载
收藏
页码：543A / 543A
页数：1
相关论文
共 50 条
  • [21] Low levels of hepatitis C virus (HCV) neutralizing antibodies in patients coinfected with HCV and human immunodeficiency virus
    Castelain, Sandrine
    Schnuriger, Aurelie
    Francois, Catherine
    Nguyen-Khac, Eric
    Fournier, Carole
    Schmit, Jean-Luc
    Capron, Dominique
    Dubuisson, Jean
    Wychowski, Czeslaw
    Thibault, Vincent
    Duverlie, Gilles
    [J]. JOURNAL OF INFECTIOUS DISEASES, 2008, 198 (03): : 332 - 335
  • [22] The clinical significance of intrahepatic hepatitis C virus (HCV) levels in patients with chronic HCV infection.
    Haydon, GH
    Jarvis, LM
    Hayes, PC
    Harrison, DJ
    [J]. HEPATOLOGY, 1996, 24 (04) : 1041 - 1041
  • [23] Anti-c1q antibodies in hepatitis C virus infection.
    Saadoun, David
    sadallah, Salima
    Limal, Nicolas
    Trendelenburg, M.
    Piette, J. C.
    Schifferli, J. A.
    Cacoub, patrice
    [J]. ARTHRITIS AND RHEUMATISM, 2006, 54 (09): : S631 - S631
  • [24] Broadly neutralizing antibodies abrogate established hepatitis C virus infection
    de Jong, Ype P.
    Dorner, Marcus
    Mommersteeg, Michiel C.
    Xiao, Jing W.
    Balazs, Alejandro B.
    Robbins, Justin B.
    Winer, Benjamin Y.
    Gerges, Sherif
    Vega, Kevin
    Labitt, Rachael N.
    Donovan, Bridget M.
    Giang, Erick
    Krishnan, Anuradha
    Chiriboga, Luis
    Charlton, Michael R.
    Burton, Dennis R.
    Baltimore, David
    Law, Mansun
    Rice, Charles M.
    Ploss, Alexander
    [J]. SCIENCE TRANSLATIONAL MEDICINE, 2014, 6 (254)
  • [25] Evaluation of HFE mutations in patients with chronic hepatitis C virus (HCV) infection.
    Halangk, J
    Witt, H
    Puhl, G
    Gäbelein, G
    Müller, T
    Landt, F
    Neuhaus, P
    Wiedenmann, B
    Luck, W
    Berg, T
    [J]. HEPATOLOGY, 2004, 40 (04) : 683A - 683A
  • [26] IL-10 hepatic deficit in hepatitis C virus (HCV) infection.
    Dharancy, S
    Leteurtre, E
    Gambiez, L
    Canva, V
    Pruvot, FR
    Paris, JC
    Desreumaux, P
    [J]. GASTROENTEROLOGY, 2000, 118 (04) : A944 - A944
  • [27] Clinical correlates of histologic grade and stage in hepatitis C virus (HCV) infection.
    Bentley, G
    Nathani, MG
    Vander Heide, RS
    Mutchnick, MG
    Turner, JR
    [J]. MODERN PATHOLOGY, 1998, 11 (01) : 151A - 151A
  • [28] Anti-endothelial cell antibodies in hepatitis C virus infection.
    Cacoub, P
    Ghillani, P
    Révélen, R
    Calvez, V
    Hausfater, P
    Musset, L
    Youinou, P
    Piette, JC
    [J]. ARTHRITIS AND RHEUMATISM, 1998, 41 (09): : S308 - S308
  • [29] Anti-endothelial cell antibodies in hepatitis C virus infection.
    Cacoub, P
    Ghillani, P
    Révélen, R
    Calvez, V
    Hausfater, P
    Musset, L
    Youinou, P
    Piette, JC
    [J]. HEPATOLOGY, 1998, 28 (04) : 685A - 685A
  • [30] Autoimmune hepatitis and hepatitis C virus infection.
    Cacoub, P
    DeLacroixSzmania, I
    Gatel, A
    Sbai, A
    Tazi, Z
    Godeau, P
    [J]. REVUE DE MEDECINE INTERNE, 1996, 17 (02): : 131 - 134
12345